Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple-Dose Safety and Tolerance Study of Desloratadine in Atopic Pediatric Subjects and Pediatric Subjects With Chronic Idiopathic Urticaria, Ages >=2 to <12 Years, Who Are Poor Metabolizers of Desloratadine

NCT00757562 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00757562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00757562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple-Dose Safety and Tolerance Study of Desloratadine in Atopic Pediatric Subjects and Pediatric Subjects With Chronic Idiopathic Urticaria, Ages >=2 to <12 Years, Who Are Poor Metabolizers of Desloratadine
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
November 1, 2002
Completion date
October 1, 2003
Enrollment
97 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atopy, chronic idiopathic urticaria